Dr. Reddy's Laboratories has reported results for first quarter ended June 30, 2021.
The company has reported a fall of 56.49% in its net profit at Rs 413.40 crore for the quarter under review as compared to Rs 950.20 crore for the same quarter in the previous year. Total income of the company decreased by 6.93% at Rs 3619.70 crore for Q1FY22 as compared Rs 3889.10 crore for the corresponding quarter previous year.
On the consolidated basis, the company has reported a fall of 36.02% in its net profit of associate at Rs 380.40 crore for the quarter under review as compared to Rs 594.60 crore for the same quarter in the previous year. However, total income of the company increased by 11.95% at Rs 5053.00 crore for Q1FY22 as compared Rs 4513.60 crore for the corresponding quarter previous year.
Company Name | CMP |
---|---|
Sun Pharma Inds. | 1520.55 |
Dr. Reddys Lab | 6217.15 |
Cipla | 1405.40 |
Zydus Lifesciences | 953.50 |
Lupin | 1589.10 |
View more.. |